Monthly Archives: March 2024
Rescheduling Cannabis & The U.S. Securities Market
In early January 2024, the U.S. Department of Health & Human Services (HHS) officially recommended rescheduling cannabis from a Schedule I drug to a Schedule III drug. While this would not lower the amount of drug-related convictions among the general populace, it would open up the possibility of greater research and commerce related to… Read More »
Does My Company Need In-House Counsel?
When a small business begins to see success, it is with the work of countless people both behind the scenes and on the proverbial front line. One of the most important performers for many businesses is their attorney – but not every business needs to have counsel in-house. Depending on several different factors, your… Read More »
